Leaflet PIMAFUCORT ointment


Indicated for: dermatoses with bacterial or fungal infection

Route of administration: cutaneous

Substance: natamycin + neomycin + hydrocortisone (polyene antifungal, aminoglycoside antibiotic and corticosteroid)

ATC: D07CA01 (Dermatologicals | Corticosteroids, combinations with antibiotics | Corticosteroids, weak, combinations with antibiotics)

Precautions:
Anaphylaxis
Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Hyperglycemia
Hyperglycemia

This medicine may increase blood sugar.

Immunosuppression / infection risk
Immunosuppression / infection risk

This medicine may increase the risk of infections.

Nephrotoxicity
Nephrotoxicity

This medicine may affect the kidneys.

Ototoxicity
Ototoxicity

This medicine may affect hearing or balance.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

General data about PIMAFUCORT

  • Substance: natamycin + neomycin + hydrocortisone
  • Date of last drug list: 01-07-2013
  • Commercial code: W01892001
  • Pharmaceutical form: ointment
  • Quantity: 1
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for natamycin + neomycin + hydrocortisone